<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35156160</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders.</ArticleTitle><Pagination><StartPage>2694</StartPage><EndPage>2701</EndPage><MedlinePgn>2694-2701</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-022-02769-8</ELocationID><Abstract><AbstractText>MicroRNAs (miRs) are regulatory RNAs with 18-25 nucleotides lengths involved in various biological processes. Some miRs, including miR-22, play an essential role in regulating neurological disorders. MiR-22 is a brain-enriched regulatory element involved in angiogenesis, energy supply, adjustment of ionic channels, and suppression of malignant cell proliferation, migration, and invasion. This article discusses the protective and therapeutic effects of miR-22 on neurological diseases and injuries, including cerebral ischemia, neurodegenerative diseases, epilepsy, and brain malignancies. We also correlated miR-22 with amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), panic disorders, schizophrenia, neural tube defect (anencephaly), and traumatic brain injury. This work provides a therapeutic perspective for miR-22 as a new approach in treating neurological disorders.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rastegar-Moghaddam</LastName><ForeName>Seyed Hamidreza</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahimzadeh-Bideskan</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Biomedical Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahba</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malvandi</LastName><ForeName>Amir Mohammad</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-1243-2372</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Biochemistry &amp; Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi, 4 - 20161, Milan, Italy. Amirmohammad.Malvandi@grupposandonato.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadipour</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9244-1193</Identifier><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Mohammadipa@mums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Biomedical Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Mohammadipa@mums.ac.ir.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Mashhad University of Medical Sciences, Azadi Sq, Vakilabad Blvd, PO Box 91779-48564, Mashhad, Iran. Mohammadipa@mums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C548375">MIRN22 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain malignancies</Keyword><Keyword MajorTopicYN="N">MicroRNA-22</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Neuroprotective</Keyword><Keyword MajorTopicYN="N">Stroke, RNA therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35156160</ArticleId><ArticleId IdType="doi">10.1007/s12035-022-02769-8</ArticleId><ArticleId IdType="pii">10.1007/s12035-022-02769-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C (2016) Distribution of miRNA expression across human tissues. Nucleic Acids Res 44(8):3865&#x2013;3877. https://doi.org/10.1093/nar/gkw116</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw116</ArticleId><ArticleId IdType="pubmed">26921406</ArticleId><ArticleId IdType="pmc">4856985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou X, Chen D, Chen N (2020) The Regulation of microRNAs in Alzheimer&#x2019;s disease. Front Neurol 11:288. https://doi.org/10.3389/fneur.2020.00288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00288</ArticleId><ArticleId IdType="pubmed">32362867</ArticleId><ArticleId IdType="pmc">7180504</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy KB (2015) MicroRNA (miRNA) in cancer. Cancer Cell Int 15:38. https://doi.org/10.1186/s12935-015-0185-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12935-015-0185-1</ArticleId><ArticleId IdType="pubmed">25960691</ArticleId><ArticleId IdType="pmc">4424445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonacci A, Bagnato G, Pandolfo G, Billeci L, Sansone F, Conte R, Gangemi S (2019) MicroRNA cross-involvement in autism spectrum disorders and atopic dermatitis: a literature review. J Clin Med 8(1):88. https://doi.org/10.3390/jcm8010088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8010088</ArticleId><ArticleId IdType="pmc">6352260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D, Qiao J, Qu Q, He F, Chen W, Yu B (2020) Weighted gene co-expression network analysis to investigate the key genes implicated in global brain ischemia/reperfusion injury in rats. Adv Clin Exp Med. 29(6):649&#x2013;659. https://doi.org/10.17219/acem/121918</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/121918</ArticleId><ArticleId IdType="pubmed">32558399</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang ZP, Wang DZ (2014) miR-22 in cardiac remodeling and disease. Trends Cardiovasc Med 24(7):267&#x2013;272. https://doi.org/10.1016/j.tcm.2014.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2014.07.005</ArticleId><ArticleId IdType="pubmed">25218673</ArticleId><ArticleId IdType="pmc">4171194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li Y, Ding M, Zhang H, Xu X, Tang J (2017) Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review). Int J Oncol 50(2):345&#x2013;355. https://doi.org/10.3892/ijo.2016.3811</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2016.3811</ArticleId><ArticleId IdType="pubmed">28000852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Liu H, Zhang J, Dong Y (2020) Circular RNA cZNF292 silence alleviates OGD/R-induced injury through up-regulation of miR-22 in rat neural stem cells (NSCs). Artif Cells Nanomed Biotechnol 48(1):594&#x2013;601. https://doi.org/10.1080/21691401.2020.1725536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21691401.2020.1725536</ArticleId><ArticleId IdType="pubmed">32052645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Zhou W, Zhou Z, Yang Q, Xu J, Dong W (2020) miR-22 and cerebral microbleeds in brainstem and deep area are associated with depression one month after ischemic stroke. Braz J Med Biol Res 53(5):e9162. https://doi.org/10.1590/1414-431x20209162</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20209162</ArticleId><ArticleId IdType="pubmed">32348425</ArticleId><ArticleId IdType="pmc">7197650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Shi C, Pan H, Meng X, Ji F (2020) MicroRNA-22 exerts its neuroprotective and angiogenic functions via regulating PI3K/Akt signaling pathway in cerebral ischemia-reperfusion rats. J Neural Transm (Vienna) 127(1):35&#x2013;44. https://doi.org/10.1007/s00702-019-02124-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-019-02124-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Mateos EM, Arribas-Blazquez M, Sanz-Rodriguez A, Concannon C, Olivos-Ore LA, Reschke CR et al (2015) microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus. Sci Rep 5:17486. https://doi.org/10.1038/srep17486</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17486</ArticleId><ArticleId IdType="pubmed">26631939</ArticleId><ArticleId IdType="pmc">4668358</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H, Cui B, Hao X (2019) MicroRNA-22 alleviates inflammation in ischemic stroke via p38 MAPK pathways. Mol Med Rep 20(1):735&#x2013;744. https://doi.org/10.3892/mmr.2019.10269</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10269</ArticleId><ArticleId IdType="pubmed">31115561</ArticleId><ArticleId IdType="pmc">6580039</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q, Len Q, Liu Z, Wang W (2018) Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Cardiovasc Ther. 36(2):e12318. https://doi.org/10.1111/1755-5922.12318</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12318</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria Lopez JA, Gonz&#xe1;lez HM, L&#xe9;ger GC (2019) Alzheimer&#x2019;s disease. Handb Clin Neurol 167:231&#x2013;255. https://doi.org/10.1016/B978-0-12-804766-8.00013-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-804766-8.00013-3</ArticleId><ArticleId IdType="pubmed">31753135</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C, Guo L, Yang Y, Guan Q, Shen H, Sheng Y, Jiao Q (2020) Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer&#x2019;s disease. Brain Behav 10(6):e01627. https://doi.org/10.1002/brb3.1627</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1627</ArticleId><ArticleId IdType="pubmed">32307887</ArticleId><ArticleId IdType="pmc">7303389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantzavinos V, Alexiou A (2017) Biomarkers for Alzheimer&#x2019;s disease diagnosis. Curr Alzheimer Res 14(11):1149&#x2013;1154. https://doi.org/10.2174/1567205014666170203125942</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205014666170203125942</ArticleId><ArticleId IdType="pubmed">28164766</ArticleId><ArticleId IdType="pmc">5684784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer&#x2019;s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541&#x2013;5554. https://doi.org/10.2147/IJN.S200490</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S200490</ArticleId><ArticleId IdType="pubmed">31410002</ArticleId><ArticleId IdType="pmc">6650620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng XR, Cui XL, Zheng Y, Zhang GR, Li P, Huang H et al (2013) Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer&#x2019;s disease animal model. Front Aging Neurosci 5:65. https://doi.org/10.3389/fnagi.2013.00065</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2013.00065</ArticleId><ArticleId IdType="pubmed">24194717</ArticleId><ArticleId IdType="pmc">3810591</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran R, Khoshdel-Sarkarizi H, Kargozar S, Hami J, Mohammadipour A, Sadr-Nabavi A, Peyvandi Karizbodagh M, Kheradmand H et al (2020) Developmental regulation and lateralisation of the &#x3b1;7 and &#x3b1;4 subunits of nicotinic acetylcholine receptors in developing rat hippocampus. Int J Dev Neurosci 80(4):303&#x2013;318. https://doi.org/10.1002/jdn.10026</Citation></Reference><Reference><Citation>Rastegar-Moghaddam SH, Mohammadipour A, Hosseini M, Bargi R, Ebrahimzadeh-Bideskan A (2019) Maternal exposure to atrazine induces the hippocampal cell apoptosis in mice offspring and impairs their learning and spatial memory. Toxin Reviews 38(4):298&#x2013;306. https://doi.org/10.1080/15569543.2018.1466804</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15569543.2018.1466804</ArticleId></ArticleIdList></Reference><Reference><Citation>Man SM, Karki R, Kanneganti TD (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277(1):61&#x2013;75. https://doi.org/10.1111/imr.12534</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12534</ArticleId><ArticleId IdType="pubmed">28462526</ArticleId><ArticleId IdType="pmc">5416822</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao L, Kan B, Shi H, Han J (2018) miR-22 exerts anti-alzheimic effects via the regulation of apoptosis of hippocampal neurons. Cell Mol Biol 64(15):84&#x2013;89</Citation><ArticleIdList><ArticleId IdType="doi">10.14715/10.14715/cmb/2017.64.15.14</ArticleId><ArticleId IdType="pubmed">30672441</ArticleId></ArticleIdList></Reference><Reference><Citation>Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661&#x2013;670. https://doi.org/10.1007/s13311-016-0483-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0483-x</ArticleId><ArticleId IdType="pubmed">27730544</ArticleId><ArticleId IdType="pmc">5081118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigham M, Mohammadipour A, Hosseini M, Malvandi AM, Ebrahimzadeh-Bideskan A (2021) Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson&#x2019;s disease: motor and non-motor outcomes. Metab Brain Dis 36(5):927&#x2013;937. https://doi.org/10.1007/s11011-021-00705-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-021-00705-8</ArticleId><ArticleId IdType="pubmed">33656625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadipour A, Haghir H, EbrahimzadehBideskan A (2020) A link between nanoparticles and Parkinson&#x2019;s disease Which nanoparticles are most harmful? Rev Environ Health 35(4):545&#x2013;556. https://doi.org/10.1515/reveh-2020-0043</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2020-0043</ArticleId><ArticleId IdType="pubmed">32681785</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari Z, Mohammadipour A, Haeri P, Ebrahimzadeh-Bideskan A (2019) The effect of titanium dioxide nanoparticles on mice midbrain substantia nigra. Iran J Basic Med Sci. 22(7):745&#x2013;751. https://doi.org/10.22038/ijbms.2019.33611.8018</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/ijbms.2019.33611.8018</ArticleId><ArticleId IdType="pubmed">32373295</ArticleId><ArticleId IdType="pmc">7196354</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CP, Zhang ZH, Zhang LH, Rui HC (2016) Neuroprotective Role of MicroRNA-22 in a 6-hydroxydopamine-induced cell model of Parkinson&#x2019;s disease via regulation of its target gene TRPM7. J Mol Neurosci 60(4):445&#x2013;452. https://doi.org/10.1007/s12031-016-0828-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-016-0828-2</ArticleId><ArticleId IdType="pubmed">27631550</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Sukumaran P, Schaar A, Singh BB (2015) TRPM7 and its role in neurodegenerative diseases. Channels (Austin) 9(5):253&#x2013;261. https://doi.org/10.1080/19336950.2015.1075675</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336950.2015.1075675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R (2013) MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington&#x2019;s disease-related mechanisms. PLoS ONE 8(1):e54222. https://doi.org/10.1371/journal.pone.0054222</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054222</ArticleId><ArticleId IdType="pubmed">23349832</ArticleId><ArticleId IdType="pmc">3547907</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda C, Tong XP (2018) Huntington&#x2019;s disease: from basic science to therapeutics. CNS Neurosci Ther 24(4):247&#x2013;249. https://doi.org/10.1111/cns.12841</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12841</ArticleId><ArticleId IdType="pubmed">29582586</ArticleId><ArticleId IdType="pmc">6489829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei Y, Shi R, Song Z, Wu J (2020) Metabolic control of epilepsy: a promising therapeutic target for epilepsy. Front Neurol 11:592514. https://doi.org/10.3389/fneur.2020.592514</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592514</ArticleId><ArticleId IdType="pubmed">33363507</ArticleId><ArticleId IdType="pmc">7753014</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs RD, Surges R, O&#x2019;Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689&#x2013;701. https://doi.org/10.1016/S0140-6736(18)32596-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32596-0</ArticleId><ArticleId IdType="pubmed">30686584</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida Silva LF, Reschke CR, Nguyen NT, Langa E, Sanz-Rodriguez A, Gerbatin RR (2020) Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice. Mol Brain 13(1):114. https://doi.org/10.1186/s13041-020-00653-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00653-x</ArticleId><ArticleId IdType="pubmed">32825833</ArticleId><ArticleId IdType="pmc">7441563</ArticleId></ArticleIdList></Reference><Reference><Citation>Beamer EH, Jurado-Arjona J, Jimenez-Mateos EM, Morgan J, Reschke CR, Kenny A et al (2018) MicroRNA-22 Controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus. Front Mol Neurosci 11:442. https://doi.org/10.3389/fnmol.2018.00442</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00442</ArticleId><ArticleId IdType="pubmed">30618601</ArticleId><ArticleId IdType="pmc">6298134</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessberger S, Parent JM (2015) Epilepsy and adult neurogenesis. Cold Spring Harb Perspect Biol 7(12):a020677. https://doi.org/10.1101/cshperspect.a020677</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020677</ArticleId><ArticleId IdType="pubmed">26552418</ArticleId><ArticleId IdType="pmc">4665072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly T, Beck H (2017) Functional properties of granule cells with hilar basal dendrites in the epileptic dentate gyrus. Epilepsia 58(1):160&#x2013;171. https://doi.org/10.1111/epi.13605</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13605</ArticleId><ArticleId IdType="pubmed">27888509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielefeld P, Dur&#xe1; I, Danielewicz J, Lucassen PJ, Baekelandt V, Abrous DN et al (2019) Insult-induced aberrant hippocampal neurogenesis: functional consequences and possible therapeutic strategies. Behav Brain Res 372:112032. https://doi.org/10.1016/j.bbr.2019.112032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.112032</ArticleId><ArticleId IdType="pubmed">31199935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Lu Q, Fei X, Shen L, Jiang D, Dai D (2016) miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1. Tumour Biol 37(5):6761&#x2013;6768. https://doi.org/10.1007/s13277-015-4575-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-4575-8</ArticleId><ArticleId IdType="pubmed">26662303</ArticleId></ArticleIdList></Reference><Reference><Citation>Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N (2018) Current challenges and opportunities in treating glioblastoma. Pharmacol Rev 70(3):412&#x2013;445. https://doi.org/10.1124/pr.117.014944</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.014944</ArticleId><ArticleId IdType="pubmed">29669750</ArticleId><ArticleId IdType="pmc">5907910</ArticleId></ArticleIdList></Reference><Reference><Citation>Soomro SH, Ting LR, Qing YY, Ren M (2017) Molecular biology of glioblastoma: classification and mutational locations. J Pak Med Assoc 67(9):1410&#x2013;1414</Citation><ArticleIdList><ArticleId IdType="pubmed">28924284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan AC, Ashley DM, L&#xf3;pez GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70(4):299&#x2013;312. https://doi.org/10.3322/caac.21613</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21613</ArticleId><ArticleId IdType="pubmed">32478924</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tu L, Zhou X, Li B (2020) MicroRNA-22 regulates the proliferation, drug sensitivity and metastasis of human glioma cells by targeting SNAIL1. J BUON 25(1):491&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pubmed">32277674</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu QF, Pan YW, Li LC, Zhou Z, Huang QL, Pang JC et al (2014) MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1. Brain Pathol 24(6):568&#x2013;583. https://doi.org/10.1111/bpa.12136</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12136</ArticleId><ArticleId IdType="pubmed">24576181</ArticleId><ArticleId IdType="pmc">8029063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Kumar US, Sadeghipour N, Massoud TF, Paulmurugan R (2021) A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic MicroRNA loading for intranasal delivery to mouse glioblastomas. ACS Nano. https://doi.org/10.1021/acsnano.1c07587</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.1c07587</ArticleId><ArticleId IdType="pubmed">34967609</ArticleId><ArticleId IdType="pmc">8887877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai H, Fan W, Wang Y, Cai Y, Li X, Chen F et al (2019) Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model. Mol Ther Nucleic Acids 18:681&#x2013;695. https://doi.org/10.1016/j.omtn.2019.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.10.002</ArticleId><ArticleId IdType="pubmed">31707205</ArticleId><ArticleId IdType="pmc">6849368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu YQ, Liao B, Liu YH, Wang Z, Zhu XH, Chen XB, Wang MQ (2019) MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis. Eur Rev Med Pharmacol Sci. 23(10):4097&#x2013;4109. https://doi.org/10.26355/eurrev_201905_17911</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_201905_17911</ArticleId><ArticleId IdType="pubmed">31173279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E et al (2019) Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials 218:119342. https://doi.org/10.1016/j.biomaterials.2019.119342</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2019.119342</ArticleId><ArticleId IdType="pubmed">31326657</ArticleId><ArticleId IdType="pmc">6663564</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Sun B, Gao X, Dong X, Fu L, Zhang Y et al (2020) Intranasal delivery of targeted nanoparticles loaded with miR-132 to brain for the treatment of neurodegenerative diseases. Front Pharmacol 11:1165. https://doi.org/10.3389/fphar.2020.01165</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01165</ArticleId><ArticleId IdType="pubmed">32848773</ArticleId><ArticleId IdType="pmc">7424054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowski L, Golubczyk D, Kwiatkowska J, Holak P, Milewska K, Janowski M et al (2021) Two in one: use of divalent manganese ions as both cross-linking and MRI contrast agent for intrathecal injection of hydrogel-embedded stem cells. Pharmaceutics 13(7):1076. https://doi.org/10.3390/pharmaceutics13071076</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13071076</ArticleId><ArticleId IdType="pubmed">34371767</ArticleId><ArticleId IdType="pmc">8309201</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H, Yang M, Pan Q, Jin HL, Li HF, Wang RR et al (2021) MicroRNA-22-3p alleviates spinal cord ischemia/reperfusion injury by modulating M2 macrophage polarization via IRF5. J Neurochem 156(1):106&#x2013;120. https://doi.org/10.1111/jnc.15042</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15042</ArticleId><ArticleId IdType="pubmed">32406529</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Xu L, Xu Y (2021) Effect of intrathecal injection of miRNA-138 on neuropathic pain in rats undergoing partial sciatic nerve ligation and its underlying mechanism. Ann Palliat Med. 10(6):6873&#x2013;6882. https://doi.org/10.21037/apm-21-669</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-21-669</ArticleId><ArticleId IdType="pubmed">34237985</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumert B, Sobu&#x15b; A, Go&#x142;&#x105;b-Janowska M, Ula&#x144;czyk Z, Paczkowska E, &#x141;uczkowska K et al (2020) Local and systemic humoral response to autologous lineage-negative cells intrathecal administration in ALS patients. Int J Mol Sci 21(3):1070. https://doi.org/10.3390/ijms21031070</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031070</ArticleId><ArticleId IdType="pmc">7037134</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng W, Tang H, Luo S, Lv Y, Liang D, Kang X, Hong W (2019) Exosomes from miRNA-126-modified ADSCs promotes functional recovery after stroke in rats by improving neurogenesis and suppressing microglia activation. Am J Transl Res 11(2):780&#x2013;792</Citation><ArticleIdList><ArticleId IdType="pubmed">30899379</ArticleId><ArticleId IdType="pmc">6413259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhang X, Chen X, Wang L, Yang G (2017) Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids 7:278&#x2013;287. https://doi.org/10.1016/j.omtn.2017.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2017.04.010</ArticleId><ArticleId IdType="pubmed">28624203</ArticleId><ArticleId IdType="pmc">5415550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu J, Su M, Wang X, Xie C (2021) Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B/BMP2/BMF axis. Stem Cell Res Ther 12(1):111. https://doi.org/10.1186/s13287-020-02091-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-02091-x</ArticleId><ArticleId IdType="pubmed">33546766</ArticleId><ArticleId IdType="pmc">7863295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ST, Im W, Ban JJ, Lee M, Jung KH, Lee SK et al (2017) Exosome-based delivery of miR-124 in a Huntington&#x2019;s disease model. J Mov Disord. 10(1):45&#x2013;52. https://doi.org/10.14802/jmd.16054</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.16054</ArticleId><ArticleId IdType="pubmed">28122430</ArticleId><ArticleId IdType="pmc">5288667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N (2015) An overview of viral and nonviral delivery systems for microRNA. Int J Pharm Investig 5(4):179&#x2013;181. https://doi.org/10.4103/2230-973X.167646</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-973X.167646</ArticleId><ArticleId IdType="pubmed">26682187</ArticleId><ArticleId IdType="pmc">4674998</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S, Bravo V&#xe1;zquez LA, P&#xe9;rez Uribe S, Roxana Reyes-P&#xe9;rez P, Sharma A (2020) Current status of microRNA-based therapeutic approaches in neurodegenerative disorders. Cells 9(7):1698. https://doi.org/10.3390/cells9071698</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071698</ArticleId><ArticleId IdType="pmc">7407981</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodr CE, Becerra A, Han Y, Bohn MC (2014) Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects. Brain Res 1550:47&#x2013;60. https://doi.org/10.1016/j.brainres.2014.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.01.010</ArticleId><ArticleId IdType="pubmed">24463035</ArticleId><ArticleId IdType="pmc">3974902</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister EL, DiNardo N, Mondo E, Borel F, Conroy F, Fraser C et al (2017) Artificial miRNAs reduce human mutant huntingtin throughout the striatum in a transgenic sheep model of Huntington&#x2019;s disease. Hum Gene Ther 29(6):663&#x2013;673. https://doi.org/10.1089/hum.2017.199</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2017.199</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F, Gernoux G, Cardozo B, Metterville JP, Toro Cabrera GC, Song L et al (2016) Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1(G93A) mice and nonhuman primates. Hum Gene Ther 27(1):19&#x2013;31. https://doi.org/10.1089/hum.2015.122</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2015.122</ArticleId><ArticleId IdType="pubmed">26710998</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahba S, Mehrzad J, Malvandi AM (2021) Neuroimmune disruptions from naturally occurring levels of mycotoxins. Environ Sci Pollut Res Int 28:32156&#x2013;32176. https://doi.org/10.1007/s11356-021-14146-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-021-14146-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D&#x2019;Errico E, Scarafino A, Distaso E, Simone IL (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288. https://doi.org/10.3389/fnmol.2018.00288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId><ArticleId IdType="pmc">6121079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Shui S, Han X, Guo D, Li T, Yan L (2016) microRNA-22 attenuates neuronal cell apoptosis in a cell model of traumatic brain injury. Am J Transl Res 8(4):1895&#x2013;1902</Citation><ArticleIdList><ArticleId IdType="pubmed">27186313</ArticleId><ArticleId IdType="pmc">4859918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Zhou J, Zhong Y, Jiang L, Mu P, Li Y, Singh N, Nagarkatti M, Nagarkatti P (2014) Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11(8):810&#x2013;818. https://doi.org/10.7150/ijms.8647</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.8647</ArticleId><ArticleId IdType="pubmed">24936144</ArticleId><ArticleId IdType="pmc">4057480</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39(5):6219&#x2013;6225. https://doi.org/10.1007/s11033-011-1441-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-011-1441-7</ArticleId><ArticleId IdType="pubmed">22231906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mui&#xf1;os-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipil&#xe4; T, Maron E et al (2011) Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 69(6):526&#x2013;533. https://doi.org/10.1016/j.biopsych</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych</ArticleId><ArticleId IdType="pubmed">21168126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WD, Yu X, Fu X, Huang S, Jin SJ, Ning Q, Luo XP (2014) MicroRNAs function primarily in the pathogenesis of human anencephaly via the mitogen-activated protein kinase signaling pathway. Genet Mol Res 13(1):1015&#x2013;1029. https://doi.org/10.4238/2014.February.20.3</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/2014.February.20.3</ArticleId><ArticleId IdType="pubmed">24634123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Zeng YJ, Sun XC (2018) Neuroprotective effects of p53/microRNA 22 regulate inflammation and apoptosis in subarachnoid hemorrhage. Int J Mol Med 41(4):2406&#x2013;2412. https://doi.org/10.3892/ijmm.2018.3392</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2018.3392</ArticleId><ArticleId IdType="pubmed">29336471</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM (2011) Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry 69(2):188&#x2013;193. https://doi.org/10.1016/j.biopsych.2010.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.09.039</ArticleId><ArticleId IdType="pubmed">21183010</ArticleId><ArticleId IdType="pmc">3038345</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>